Underground ibogaine use for the treatment of substance use disorders: aqualitative analysis of subjective experiences (2023)
- Authors:
- USP affiliated authors: SANTOS, RAFAEL GUIMARÃES DOS - FMRP ; HALLAK, JAIME EDUARDO CECILIO - FMRP
- Unidade: FMRP
- DOI: 10.1111/dar.13587
- Subjects: ALUCINOGÊNICOS; TRANSTORNOS RELACIONADOS AO USO DE SUBSTÂNCIAS; ALCALOIDES; FARMACOTERAPIA
- Keywords: Hallucinogenic; Iboga; Psychedelic; Qualitative analysis; Substance use disorders
- Language: Inglês
- Imprenta:
- Publisher place: Chichester
- Date published: 2023
- Source:
- Título: Drug and Alcohol Review
- ISSN: 0959-5236
- Volume/Número/Paginação/Ano: v. 42, n. 2, p. 401-414, 2023
- Status:
- Artigo possui acesso gratuito no site do editor (Bronze Open Access)
- Versão do Documento:
- Versão publicada (Published version)
- Acessar versão aberta:
-
ABNT
RODRÍGUEZ‐CANO, Borja J. et al. Underground ibogaine use for the treatment of substance use disorders: aqualitative analysis of subjective experiences. Drug and Alcohol Review, v. 42, n. 2, p. 401-414, 2023Tradução . . Disponível em: https://doi.org/10.1111/dar.13587. Acesso em: 02 abr. 2026. -
APA
Rodríguez‐Cano, B. J., Kohek, M., Ona, G., Alcázar‐Córcoles, M. Á., Santos, R. G. dos, Hallak, J. E. C., & Bouso, J. C. (2023). Underground ibogaine use for the treatment of substance use disorders: aqualitative analysis of subjective experiences. Drug and Alcohol Review, 42( 2), 401-414. doi:10.1111/dar.13587 -
NLM
Rodríguez‐Cano BJ, Kohek M, Ona G, Alcázar‐Córcoles MÁ, Santos RG dos, Hallak JEC, Bouso JC. Underground ibogaine use for the treatment of substance use disorders: aqualitative analysis of subjective experiences [Internet]. Drug and Alcohol Review. 2023 ; 42( 2): 401-414.[citado 2026 abr. 02 ] Available from: https://doi.org/10.1111/dar.13587 -
Vancouver
Rodríguez‐Cano BJ, Kohek M, Ona G, Alcázar‐Córcoles MÁ, Santos RG dos, Hallak JEC, Bouso JC. Underground ibogaine use for the treatment of substance use disorders: aqualitative analysis of subjective experiences [Internet]. Drug and Alcohol Review. 2023 ; 42( 2): 401-414.[citado 2026 abr. 02 ] Available from: https://doi.org/10.1111/dar.13587 - Psychedelic medicines in major depression: progress and future challenges
- Hallucinogens/psychedelics resurrected as new tools in psychiatric therapy [Editorial]
- Hallucinations and hallucinogens: psychopathology or wisdom?
- Ayahuasca-enhanced extinction of fear behaviour: role ofinfralimbic cortex 5-HT 2A and 5-HT 1A receptors
- Psychedelics in psychiatry
- Acute psychological adverse reactions in first-time ritual ayahuasca users: a prospective case series
- Risk assessment of ayahuasca use in a religious context: self-reported risk factors and adverse effects
- Hallucinogenic/psychedelic 5HT2A receptor agonists as rapid antidepressant therapeutics: evidence and mechanisms of action
- Effects of ayahuasca on mental health and quality of life in naïve users: a longitudinal and cross-sectional study combination
- Why N,N-dimethyltryptamine matters: unique features and therapeutic potential beyond classical psychedelics
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003200950.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
